Does Fibrinolytic Strategy of Pulmonary Embolism International THrOmbolysis (PEITHO)-3 Trial Need More Strong Evidence?-Reference-Cited by-同舟云学术

Does Fibrinolytic Strategy of Pulmonary Embolism International THrOmbolysis (PEITHO)-3 Trial Need More Strong Evidence?

Published:2022-07-12 Issue:12 Volume:122 Page:2050-2051
ISSN:0340-6245
Container-title:Thrombosis and Haemostasis
language:en
Short-container-title:Thromb Haemost

Author:

Güner Ahmet¹,Kahraman Serkan¹,Ertürk Mehmet¹

Affiliation:

1. Department of Cardiology, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey

Publisher

Georg Thieme Verlag KG

Subject

Hematology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1897-7141.pdf

Reference9 articles.

1. Reduced-dose intravenous thrombolysis for acute intermediate-high-risk pulmonary embolism: rationale and design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial;O Sanchez;Thromb Haemost,2022

2. Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial);M Sharifi;Am J Cardiol,2013

3. Low-dose systemic thrombolytic therapy for treatment of submassive pulmonary embolism: clinical efficacy but attendant hemorrhagic risks;D P Rothschild;Catheter Cardiovasc Interv,2019

4. Low-dose thrombolysis for submassive pulmonary embolism;E S Yilmaz;J Investig Med,2021

5. Low-dose alteplase for the treatment of submassive pulmonary embolism: a case series;S N Layman;J Pharm Pract,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism;Turkish Journal of Trauma and Emergency Surgery;2023

2. Response: Does Fibrinolytic Strategy of Pulmonary Embolism International ThrOmbolysis (PEITHO)-3 Trial Need More Strong Evidence?;Thrombosis and Haemostasis;2022-10-28